Published in J Virol on May 01, 1971
Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci U S A (1980) 3.97
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc Natl Acad Sci U S A (1984) 3.58
Structure of hepatitis B Dane particle DNA before and after the Dane particle DNA polymerase reaction. J Virol (1977) 3.57
Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A (1992) 2.43
Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34
Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci U S A (1982) 2.20
Demonstration of subpopulations of Dane particles. J Virol (1976) 2.14
Proteins of hepatitis B surface antigen. J Virol (1977) 1.71
Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J Virol (1972) 1.70
T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. Gut (1977) 1.42
Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats. Infect Immun (1972) 1.41
Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc Natl Acad Sci U S A (1985) 1.36
Biochemical characterization of Australia antigen. Evidence for defective particles of hepatitis B virus. Am J Pathol (1975) 1.35
Distinctive properties of the hepatitis B virus envelope proteins. J Virol (1988) 1.32
Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J (1978) 1.31
Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw. J Virol (1975) 1.29
Multiple chemical forms of hepatitis B surface antigen produced in yeast. Proc Natl Acad Sci U S A (1985) 1.22
Expression of hepatitis B surface antigen in unselected cell culture transfected with recircularized HBV DNA. EMBO J (1982) 1.21
Proteins of hepatitis B surface antigen: amino acid compositions of the major polypeptides. J Virol (1977) 1.19
Expression of hepatitis B surface antigen gene in yeast. Proc Natl Acad Sci U S A (1983) 1.17
Haemagglutination inhibition assay of the common determinants and subspecificities of Australia antigen. Immunology (1974) 1.12
Nonoverlapping antigenic sites of woodchuck hepatitis virus surface antigen and their cross-reactivity with ground squirrel hepatitis virus and hepatitis B virus surface antigens. J Virol (1983) 1.12
Reduction and reoxidation of Australia antigen: loss and reconstitution of particle structure and antigenicity. J Virol (1972) 1.11
Enhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector. Mol Cell Biol (1983) 1.09
Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children. Am J Pathol (1980) 1.08
Purification and biophysical characterization of hepatitis B antigen. J Clin Invest (1973) 1.03
HBsAg immune complexes in the course of infection with hepatitis B virus. Clin Exp Immunol (1979) 1.03
Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol (2014) 0.98
Concentration and purification of hepatitis B antigen with polyethylene glycol and polyelectrolyte 60, a cross-linked copolymer of isobutylene maleic anhydride. Infect Immun (1972) 0.92
N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen. Antimicrob Agents Chemother (1979) 0.92
Relationship of large hepatitis B surface antigen polypeptide to human serum albumin. Infect Immun (1980) 0.88
Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue. J Clin Pathol (1978) 0.87
Self-assembling protein nanoparticles in the design of vaccines. Comput Struct Biotechnol J (2015) 0.87
Large-scale purification of hepatitis B surface antigen. J Clin Microbiol (1976) 0.85
Global screening for human viral pathogens. Emerg Infect Dis (2003) 0.83
Two distinct types of hepatitis in experimental hepatitis B virus infection. Am J Pathol (1980) 0.83
Interactions of standard antibody with Australia antigens in Au Ag-Ab radioimmunoassay. Appl Microbiol (1974) 0.78
Serology and epidemiology. West J Med (1975) 0.75
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci (1964) 127.96
DISC ELECTROPHORESIS. I. BACKGROUND AND THEORY. Ann N Y Acad Sci (1964) 26.94
A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis. Anal Biochem (1967) 7.96
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med (1967) 7.00
Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature (1968) 6.34
Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81
Relation of Australia-SH antigen to the willowbrook MS-2 strain. N Engl J Med (1969) 4.13
Hepatitis antigen. Correlation with disease and infectivity of blood-donors. Lancet (1969) 4.03
Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science (1969) 3.98
Detection of Australia antigen and antibody by means of radioimmunoassay techniques. J Infect Dis (1970) 3.89
[Immunoelectrophoretic detection of the "hepatitis associated antigen" (Au-SH-antigen)]. Klin Wochenschr (1970) 3.49
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
Observations on Australia antigen in Japanese. Vox Sang (1968) 2.57
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Additional specificities of Australia antigen and the possible identification of hepatitis carriers. Nature (1969) 2.28
Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. J Infect Dis (1970) 1.62
Specificities of human antibodies to Australia antigen. Proc Soc Exp Biol Med (1970) 1.20
Analytical techniques for cell fractions. XV. Rotor B-XXIX--a new high-resolution zonal centrifuge rotor for virus isolation and cell fractionation. Anal Biochem (1969) 1.05
Digital computation of sedimentation coefficients in zonal centrifuges. Natl Cancer Inst Monogr (1966) 1.00
Preparation and recovery of cesium compounds for density gradient solutions. Natl Cancer Inst Monogr (1966) 0.86
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
DNA polymerase associated with human hepatitis B antigen. J Virol (1973) 10.71
Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92
Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23
Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A (1997) 6.09
A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A (1997) 6.07
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol (1966) 5.61
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12
An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79
A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A (2001) 4.62
Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28
Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13
Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virology (1999) 4.04
Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol (2002) 3.83
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 3.72
Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55
A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53
Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proc Natl Acad Sci U S A (1981) 3.38
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A (1993) 3.37
Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31
Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet (1980) 3.31
Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18
Antigens of hepatitis delta virus in the liver and serum of humans and animals. J Infect Dis (1986) 3.08
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06
ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol (1971) 2.98
Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96
An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol (1982) 2.94
HLA class II antibodies in transfusion-related acute lung injury. Transfusion (2001) 2.93
Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol (1987) 2.83
Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A (1994) 2.83
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81
A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. Am J Epidemiol (1966) 2.81
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology (1998) 2.76
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol (2000) 2.73
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70
Compact organization of the hepatitis B virus genome. Hepatology (1989) 2.70
Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis (1987) 2.68
Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67
Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis (1974) 2.66
Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J Clin Microbiol (1978) 2.64
Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A (1992) 2.64
Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis (1995) 2.63
Immunochemical identification of viral and nonviral proteins of the respiratory syncytial virus virion. Infect Immun (1982) 2.61
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med (1989) 2.58
A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58
The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol (1980) 2.57
In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc Natl Acad Sci U S A (1999) 2.56
Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A (1987) 2.56
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med (1994) 2.55
Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol (1995) 2.54
Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol (1997) 2.48
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Biophysical properties of Australia antigen. J Virol (1969) 2.45
Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology (1996) 2.44
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41
Hepatitis B and hepatitis C in emergency department patients. N Engl J Med (1992) 2.39
Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol (2001) 2.38
Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1992) 2.30
Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet (1979) 2.29